Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

THIOTEPA

THIOTEPA

Standard Dose
30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview THIOTEPA is listed in Drugs@FDA under application 075730 (ANDA).

Marketing status: Discontinued Active ingredient THIOTEPA Form and strength INJECTABLE;INJECTION - 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2001-04-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview THIOTEPA is listed in Drugs@FDA under application 075730 (ANDA). Marketing status: Discontinued Active ingredient THIOTEPA Form and strength INJECTABLE;INJECTION - 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor TEVA PARENTERAL Submission history Latest submission status date: 2001-04-20 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.